Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Influence of particle size on regional lung deposition--what evidence is there?

Carvalho TC, Peters JI, Williams RO 3rd.

Int J Pharm. 2011 Mar 15;406(1-2):1-10. doi: 10.1016/j.ijpharm.2010.12.040. Epub 2011 Jan 11. Review.

PMID:
21232585
2.

Deposition of non-spherical particles in bifurcating airways.

Bunchatheeravate P, Curtis JS.

Pharm Dev Technol. 2014 Dec;19(8):942-51. doi: 10.3109/10837450.2013.840848.

PMID:
24320756
4.

Using helium-oxygen to improve regional deposition of inhaled particles: mechanical principles.

Katz I, Pichelin M, Montesantos S, Majoral C, Martin A, Conway J, Fleming J, Venegas J, Greenblatt E, Caillibotte G.

J Aerosol Med Pulm Drug Deliv. 2014 Apr;27(2):71-80. doi: 10.1089/jamp.2013.1072. Epub 2014 Jan 2.

PMID:
24383961
5.

Measurement techniques for respiratory tract deposition of airborne nanoparticles: a critical review.

Löndahl J, Möller W, Pagels JH, Kreyling WG, Swietlicki E, Schmid O.

J Aerosol Med Pulm Drug Deliv. 2014 Aug;27(4):229-54. doi: 10.1089/jamp.2013.1044. Epub 2013 Oct 23. Review.

6.

Model of the deposition of aerosol particles in the respiratory tract of the rat. II. Hygroscopic particle deposition.

Ferron GA, Upadhyay S, Zimmermann R, Karg E.

J Aerosol Med Pulm Drug Deliv. 2013 Apr;26(2):101-19. doi: 10.1089/jamp.2011.0965.

PMID:
23550602
7.

The co-imaging of gamma camera measurements of aerosol deposition and respiratory anatomy.

Conway J, Fleming J, Bennett M, Havelock T.

J Aerosol Med Pulm Drug Deliv. 2013 Jun;26(3):123-30. doi: 10.1089/jamp.2011.0960. Epub 2013 Mar 21. Review.

PMID:
23517170
8.

Deposition, imaging, and clearance: what remains to be done?

Scheuch G, Bennett W, Borgström L, Clark A, Dalby R, Dolovich M, Fleming J, Gehr P, Gonda I, O'Callaghan C, Taylor G, Newman S.

J Aerosol Med Pulm Drug Deliv. 2010 Dec;23 Suppl 2:S39-57. doi: 10.1089/jamp.2010.0839. Review.

PMID:
21133799
9.

Standardization of techniques for using single-photon emission computed tomography (SPECT) for aerosol deposition assessment of orally inhaled products.

Fleming J, Bailey DL, Chan HK, Conway J, Kuehl PJ, Laube BL, Newman S.

J Aerosol Med Pulm Drug Deliv. 2012 Dec;25 Suppl 1:S29-51. doi: 10.1089/jamp.2012.1Su5.

PMID:
23215845
10.

Challenges in assessing regional distribution of inhaled drug in the human lungs.

Newman S, Fleming J.

Expert Opin Drug Deliv. 2011 Jul;8(7):841-55. doi: 10.1517/17425247.2011.577063. Epub 2011 May 10. Review.

PMID:
21554149
11.

Characterization of respiratory deposition of fluticasone-salmeterol hydrofluoroalkane-134a and hydrofluoroalkane-134a beclomethasone in asthmatic patients.

Leach CL, Kuehl PJ, Chand R, Ketai L, Norenberg JP, McDonald JD.

Ann Allergy Asthma Immunol. 2012 Mar;108(3):195-200. doi: 10.1016/j.anai.2012.01.010.

PMID:
22374204
12.

The use of combined single photon emission computed tomography and X-ray computed tomography to assess the fate of inhaled aerosol.

Fleming J, Conway J, Majoral C, Tossici-Bolt L, Katz I, Caillibotte G, Perchet D, Pichelin M, Muellinger B, Martonen T, Kroneberg P, Apiou-Sbirlea G.

J Aerosol Med Pulm Drug Deliv. 2011 Feb;24(1):49-60. doi: 10.1089/jamp.2010.0843. Epub 2010 Dec 18.

13.

Controlled, parametric, individualized, 2D and 3D imaging measurements of aerosol deposition in the respiratory tract of healthy human volunteers: in vivo data analysis.

Majoral C, Fleming J, Conway J, Katz I, Tossici-Bolt L, Pichelin M, Montesantos S, Caillibotte G.

J Aerosol Med Pulm Drug Deliv. 2014 Oct;27(5):349-62. doi: 10.1089/jamp.2013.1065. Epub 2014 Jan 8.

PMID:
24400875
14.

Effect of particle size of dry powder mannitol on the lung deposition in healthy volunteers.

Glover W, Chan HK, Eberl S, Daviskas E, Verschuer J.

Int J Pharm. 2008 Feb 12;349(1-2):314-22. Epub 2007 Aug 19.

PMID:
17904774
15.

Methods of calculating lung delivery and deposition of aerosol particles.

Kim CS.

Respir Care. 2000 Jun;45(6):695-711. Review.

PMID:
10894462
16.

Regional particle size dependent deposition of inhaled aerosols in rats and mice.

Kuehl PJ, Anderson TL, Candelaria G, Gershman B, Harlin K, Hesterman JY, Holmes T, Hoppin J, Lackas C, Norenberg JP, Yu H, McDonald JD.

Inhal Toxicol. 2012 Jan;24(1):27-35. doi: 10.3109/08958378.2011.632787. Epub 2011 Dec 7.

PMID:
22145784
17.

Aerosol deposition in the human lung in reduced gravity.

Darquenne C.

J Aerosol Med Pulm Drug Deliv. 2014 Jun;27(3):170-7. doi: 10.1089/jamp.2013.1079. Review.

18.

Validation of radiolabeling of drug formulations for aerosol deposition assessment of orally inhaled products.

Devadason SG, Chan HK, Haeussermann S, Kietzig C, Kuehl PJ, Newman S, Sommerer K, Taylor G.

J Aerosol Med Pulm Drug Deliv. 2012 Dec;25 Suppl 1:S6-9. doi: 10.1089/jamp.2012.1Su3.

PMID:
23215848
19.

Lung physiology and aerosol deposition imaged with positron emission tomography.

Venegas J, Winkler T, Harris RS.

J Aerosol Med Pulm Drug Deliv. 2013 Feb;26(1):1-8. doi: 10.1089/jamp.2011.0944. Epub 2012 Aug 2. Review.

PMID:
22856557
20.

The pulmonary deposition of two aerosol preparations of nedocromil sodium delivered by MDI assessed by single photon emission computed tomography.

Summers QA, Fleming JS, Dai Y, Perring S, Honeywell R, Gough KJ, Renwick AG, Clark AR, Nassim MA, Holgate ST.

J Aerosol Med. 1996 Mar;9 Suppl 1:S93-109.

PMID:
10160062

Supplemental Content

Support Center